bioRxiv · 10.1101/2023.10.28.564096
Inhalation Delivered RNA Aptamer for Therapeutics against SARS-CoV2
Abstract
The continual emergence and re-emergence of infectious diseases has led to a pressing need for the development of swift and targeted therapeutic interventions. SARS-CoV-2, the causative agent of COVID-19, is a prime example of such a rapidly spreading virus[1]. The global crisis caused by this virus has propelled researchers to explore and adopt novel techniques in the hopes of effectively combating its spread[2]. One such innovative approach is the use of aptamers--single-stranded RNA molecules that can bind targets with high specificity.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Song, M., Zhou, J., Herrara, A., Bains, P., Rossi, J.. 2023-10-30. Inhalation Delivered RNA Aptamer for Therapeutics against SARS-CoV2. https://doi.org/10.1101/2023.10.28.564096
Cite the original work for its findings. Save a collection to share your selection of sources.